Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: an analysis of tat and C2-V3 env regions.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: an analysis of tat and C2-V3 env regions.

AIDS. 1994 Jul;8(7):901-9. Unique Identifier : AIDSLINE GENBANK/U00272
Sabino E; Pan LZ; Cheng-Mayer C; Mayer A; Irwin Memorial Blood Centers, San Francisco, CA 94118.

Abstract: OBJECTIVE: To determine whether the HIV-1 genomes that grow out in vitro from peripheral blood mononuclear cells (PBMC) better represent the in vivo quasi-species present in plasma or PBMC. RESULTS: For one patient (9606), PBMC culture represented more accurately the plasma rather than the in vivo PBMC quasi-species distribution, because a large number of tat-defective proviruses present in PBMC in vivo were not detected in plasma nor in the PBMC cultures. For a second patient (9605), PBMC culture was representative of both in vivo PBMC and plasma tat sequences, but selection of C2-V3 env sequences was observed in PBMC cultures compared with sequences present in both plasma and PBMC in vivo. This selection consisted of the absence in vitro of genomes with certain amino-acid substitutions at or near conserved glycosylation sites of the C2 region at positions 276 and 289. Site 276 has been reported to be important for viral infectivity, and these substitutions may therefore have affected infectivity. In the third patient (10095), selection of both tat and C2-V3 sequences was observed in culture as compared to plasma and PBMC in vivo. In contrast to the first two patients, this third patient contained V3 sequences in vivo that were predicted to impart syncytium induction and enhanced replication capacity. It was these sequences that grew out preferentially in vitro. CONCLUSION: This study suggests that short-term PBMC culture is representative of HIV-1 genomes present in PBMC and plasma in vivo to the degree that they are infectious.

Keywords: Amino Acid Sequence Base Sequence Cells, Cultured Comparative Study Cytopathogenic Effect, Viral DNA, Viral/GENETICS *Genes, env *Genes, tat Genotype Glycosylation Human HIV Envelope Protein gp120/*GENETICS/METABOLISM HIV Infections/*MICROBIOLOGY HIV-1/GENETICS/*ISOLATION & PURIF/PATHOGENICITY Leukocytes, Mononuclear/*MICROBIOLOGY Molecular Sequence Data Peptide Fragments/*GENETICS/METABOLISM Plasma/*MICROBIOLOGY Polymerase Chain Reaction Protein Processing, Post-Translational Proviruses/GENETICS/ISOLATION & PURIF Selection (Genetics) Sequence Alignment Species Specificity Variation (Genetics) Viremia/*MICROBIOLOGY Virus Cultivation JOURNAL ARTICLE
950228
M9521006

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .